Africa: WHO Welcomes Preliminary Results about Dexamethasone Use in Treating Critically Ill COVID-19 Patients

[WHO] Geneva -The World Health Organization (WHO) welcomes the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO.Read the Original Article